Pantalis Injection

Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech
Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech
Pantalis 40 Injection VOCLAV 625 Rbvoc-DSR Rabeprazole Listuss - Syrup Vocalis SP Pantalis-D Listus-AM DIVOC CEFOTEM-1.5 INJ CEFTRALIS INJ
VOCLAV 625 Rbvoc-DSR Rabeprazole Listuss - Syrup Vocalis SP Pantalis-D Listus-AM DIVOC VOCLAV 625 Azivoc-500 tab Rbvoc-DSR Rabeprazole

Explore Our Prodcuts

Pantalis 40 Injection delivers fast and effective relief for patients suffering from acid reflux, GERD (Gastroesophageal Reflux Disease), and other upper gastrointestinal disorders. Formulated with Pantoprazole 40 mg, it works by reducing stomach acid production, promoting rapid symptom relief, and enabling mucosal healing. It is highly effective in the treatment of NSAID-induced gastritis, functional dyspepsia, non-ulcer dyspepsia, and erosive esophagitis.

Backed by clinical data, Pantalis 40 shows a 72.34% success rate in healing erosive GERD, along with high symptom improvement rates. Its lyophilized form ensures stability and precise dosing for intravenous administration. Recommended for hospital use and acute care settings, Pantalis 40 is a safe, trusted, and scientifically advanced solution that restores comfort and improves quality of life for patients with gastrointestinal distress.

Research & Clinical Data for Pantalis 40

Indications Supported by Evidence

  • NSAIDs-Induced Gastritis: Demonstrated reduction in gastric mucosal inflammation and pain severity.
  • Functional & Non-Ulcer Dyspepsia: Improved gastric emptying time and reduced bloating and epigastric discomfort.
  • Erosive Esophagitis: Shown to accelerate epithelial healing and reduce recurrence.